NMDA antagonists exert distinct effects in experimental organophosphate or carbamate poisoning in mice

Toxicology and Applied Pharmacology

Volumn 219, Issue 2-3, 2007, Pages 114-121

  Dekundy, Andrzej ^a   Kaminski, Rafal M ^a   Zielinska, Elzbieta ^a   Turski, Waldemar A ^a,b  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Anticholinesterase; Atropine; Lethality; Mice; NMDA antagonist; Seizures

Indexed keywords

4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; ATROPINE; CARBAMIC ACID; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DICHLORVOS; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; ORGANOPHOSPHATE; PHYSOSTIGMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INTOXICATION; LETHALITY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ATROPINE; CARBAMATES; CHOLINESTERASE INHIBITORS; DICHLORVOS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; LETHAL DOSE 50; MALE; MICE; N-METHYLASPARTATE; PIPERAZINES; SEIZURES;

MAMMALIA; MUS;

EID: 33847144039     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.10.030     Document Type: Article

References (54)

1. Bardin P.G., van Eeden S.F., Moolman J.A., Foden A.P., and Joubert J.R. Organophosphate and carbamate poisoning. Arch. Intern. Med. 154 (1994) 1433-1441
2. Bowden C.A., and Krenzelok E.P. Clinical applications of commonly used contemporary antidotes. A US perspective. Drug Saf. 16 (1997) 9-47
3. Braitman D.J., and Sparenborg S. MK-801 protects against seizures induced by the cholinesterase inhibitor soman. Brain Res. Bull. 23 (1989) 145-148
4. Cable G.G., and Doherty S. Acute carbamate and organochlorine toxicity causing convulsions in an agricultural pilot: a case report. Aviat. Space Environ. Med. 70 (1999) 68-72
5. Carpentier P., Foquin-Tarricone A., Bodjarian N., Rondouin G., Lerner-Natoli M., Kamenka J.M., Blanchet G., Denoyer M., and Lallement G. Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning. Neurotoxicology 15 (1994) 837-851
6. Chu Z.G., Zhou F.M., and Hablitz J.J. Nicotinic acetylcholine receptor-mediated synaptic potentials in rat neocortex. Brain Res. 887 (2000) 399-405
7. Clement J.G. Central activity of acetylcholinesterase oxime reactivators. Toxicol. Appl. Pharmacol. 112 (1992) 104-109
8. Clement J.G. Toxicity of the combined nerve agents GB/GF in mice: efficacy of atropine and various oximes as antidotes. Arch. Toxicol. 68 (1994) 64-66
9. Coelho F., and Birks J. Physostigmine for Alzheimer's disease. Cochrane Database Syst Rev CD001499 (2001)
10. Dawson R.M. Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 14 (1994) 317-331
11. Dekundy A. Co-administration of memantine with acetylcholinesterase inhibitors: preclinical and clinical evidence. In: Gupta R.C. (Ed). Toxicology of Organophosphate and Carbamate Compounds (2006), Elsevier, San Diego 35-46
12. Dekundy A., Blaszczak P., Kaminski R., and Turski W.A. On the interactions between antimuscarinic atropine and NMDA receptor antagonists in anticholinesterase-treated mice. Arch. Toxicol. 74 (2001) 702-708
13. Dekundy A., Kaminski R.M., and Turski W.A. Dizocilpine improves beneficial effects of cholinergic antagonists in anticholinesterase-treated mice. Toxicol. Sci. 72 (2003) 289-295
14. Deshpande S.S., Smith C.D., and Filbert M.G. Assessment of primary neuronal culture as a model for soman-induced neurotoxicity and effectiveness of memantine as a neuroprotective drug. Arch. Toxicol. 69 (1995) 384-390
15. Ellman G.L., Courtney K.D., Andres Jr. V., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
16. Finney, D.J., 1948. The Fisher-Yates test of significance in 2x2 contingency tables. Biometrika 35, 145-156. 48.
17. Fukuto T.R. Mechanism of action of organophosphorus and carbamate insecticides. Environ. Health Perspect. 87 (1990) 245-254
18. Galli A., and Mori F. Acetylcholinesterase inhibition and protection by dizocilpine (MK-801) enantiomers. J. Pharm. Pharmacol. 48 (1996) 71-76
19. Gupta R.C. Carbofuran toxicity. J. Toxicol. Environ. Health 43 (1994) 383-418
20. Gupta R.C., and Kadel W.L. Prevention and antagonism of acute carbofuran intoxication by memantine and atropine. J. Toxicol. Environ. Health 28 (1989) 111-122
21. Holstege C.P., Kirk M., and Sidell F.R. Chemical warfare. Nerve agent poisoning. Crit. Care Clin. 13 (1997) 923-942
22. Honchar M.P., Olney J.W., and Sherman W.R. Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science 220 (1983) 323-325
23. Johnson P.S., and Michaelis E.K. Characterization of organophosphate interactions at N-methyl-d-aspartate receptors in brain synaptic membranes. Mol. Pharmacol. 41 (1992) 750-756
24. Karalliedde L. Organophosphorus poisoning and anaesthesia. Anaesthesia 54 (1999) 1073-1088
25. Kis J., Czuczwar M., Zielinska E., Bojar I., Czuczwar S.J., and Turski W.A. Kynurenic acid does not protect against nicotine-induced seizures in mice. Pol. J. Pharmacol. 52 (2000) 477-480
26. Klemm W.R. Efficacy and toxicity of drug combinations in treatment of physostigmine toxicosis. Toxicology 27 (1983) 41-53
27. Lallement G., Baubichon D., Clarencon D., Galonnier M., Peoc'h M., and Carpentier P. Review of the value of gacyclidine (GK-11) as adjuvant medication to conventional treatments of organophosphate poisoning: primate experiments mimicking various scenarios of military or terrorist attack by soman. Neurotoxicology 20 (1999) 675-684
28. Lifshitz M., Shahak E., Bolotin A., and Sofer S. Carbamate poisoning in early childhood and in adults. J. Toxicol., Clin. Toxicol. 35 (1997) 25-27
29. Litchfield J.T., and Wilcoxon F. A simplified method of evaluating dose effect experimenta. J. Pharmacol. Exp. Ther. 96 (1949) 99-113
30. Markram H., and Segal M. Activation of protein kinase C suppresses responses to NMDA in rat CA1 hippocampal neurones. J. Physiol. (London) 457 (1992) 491-501
31. Marrs T.C. Toxicology of oximes used in treatment of organophosphate poisoning. Adverse Drug React. Toxicol. Rev. 10 (1991) 61-73
32. McDonough Jr. J.H., and Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 21 (1997) 559-579
33. McGehee D.S., Heath M.J., Gelber S., Devay P., and Role L.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors [see comments]. Science 269 (1995) 1692-1696
34. McLean M.J., Gupta R.C., Dettbarn W.D., and Wamil A.W. Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat. Toxicol. Appl. Pharmacol. 112 (1992) 95-103
35. Millard C.B., and Broomfield C.A. Anticholinesterases: medical applications of neurochemical principles. J. Neurochem. 64 (1995) 1909-1918
36. Munro N.B., Watson A.P., Ambrose K.R., and Griffin G.D. Treating exposure to chemical warfare agents: implications for health care providers and community emergency planning. Environ. Health Perspect. 89 (1990) 205-215
37. Ohbu S., Yamashina A., Takasu N., Yamaguchi T., Murai T., Nakano K., Matsui Y., Mikami R., Sakurai K., and Hinohara S. Sarin poisoning on Tokyo subway. South Med. J. 90 (1997) 587-593
38. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32 (1972) 281-294
39. Shannon M. Toxicology reviews: physostigmine. Pediatr. Emerg. Care 14 (1998) 224-226
40. Sherby S.M., Eldefrawi A.T., Albuquerque E.X., and Eldefrawi M.E. Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor. Mol. Pharmacol. 27 (1985) 343-348
41. Shih T.M. Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res. 7 (1990) 105-116
42. Shih T.M., and McDonough Jr. J.H. Neurochemical mechanisms in soman-induced seizures. J. Appl. Toxicol. 17 (1997) 255-264
43. Shih T.M., and McDonough Jr. J.H. Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacol. Biochem. Behav. 64 (1999) 147-153
44. Shih T.M., Koviak T.A., and Capacio B.R. Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci. Biobehav. Rev. 15 (1991) 349-362
45. Solberg Y., and Belkin M. The role of excitotoxicity in organophosphorous nerve agents central poisoning. Trends Pharmacol. Sci. 18 (1997) 183-185
46. Sparenborg S., Brennecke L.H., Jaax N.K., and Braitman D.J. Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman. Neuropharmacology 31 (1992) 357-368
47. Starr M.S., and Starr B.S. Glutamate-dopamine interactions in the production of pilocarpine motor seizures in the mouse. J. Neural Transm., Parkinson's Dis. Dement. Sect. 6 (1993) 109-117
48. Urbanska E., Dekundy A., Kleinrok Z., Turski W.A., and Czuczwar S.J. Glutamatergic receptor agonists and brain pathology. In: Kostrzewa R.M. (Ed). Highly Selective Neurotoxins. Basic and Clinical Applications (1998), Humana Press Inc., Totowa, NJ 329-354
49. Wenk G.L., Quack G., Moebius H.J., and Danysz W. No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use. Life Sci. 66 (2000) 1079-1083
50. WHO Working Group. Dichlorvos. Environmental Health Criteria vol. 79 (1989)
51. Wilkinson D.G., Francis P.T., Schwam E., and Payne-Parrish J. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging 21 (2004) 453-478
52. Worek F., Backer M., Thiermann H., Szinicz L., Mast U., Klimmek R., and Eyer P. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Human Exp. Toxicol. 16 (1997) 466-472
53. Yamashita M., Tanaka J., and Ando Y. Human mortality in organophosphate poisonings. Vet. Hum. Toxicol. 39 (1997) 84-85
54. Zhou Z., Dai X., Gu X., Sun Y., Zheng G., and Zheng J. Memantine alleviates toxicity induced by dichlorvos in rats. J. Occup. Health 47 (2005) 96-101